Menu Search
Equities

Mesa Laboratories Inc

MLIG:DEU

Mesa Laboratories Inc

Actions
  • Price (EUR)108.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-25.00%
  • Beta--
Data delayed at least 15 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Mesa Laboratories, Inc. is a multinational manufacturer, developer, and seller of life sciences tools and critical quality control solutions. Its segments include Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. Its Clinical Genomics segment develops, manufactures, and sells throughput genetic analysis tools used by labs to perform clinical genomic testing in several therapeutic areas. Its Sterilization and Disinfection Control segment manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Calibration Solutions segment develops, manufactures, and sells quality control products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters.

  • Revenue in USD (TTM)212.87m
  • Net income in USD948.00k
  • Incorporated1982
  • Employees698.00
  • Location
    Mesa Laboratories Inc12100 W 6th AveLAKEWOOD 80228-1252United StatesUSA
  • Phone+1 (303) 987-8000
  • Fax+1 (303) 987-8989
  • Websitehttps://mesalabs.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		MLAB:NSQ since
announced		Transaction
value
SAL Schiffahrtskontor Altes Land GmbH & Co KGDeal completed16 Oct 202316 Oct 2023Deal completed20.47%89.33m
gke-GmbH-Sterilization Indicators BusinessDeal completed16 Oct 202316 Oct 2023Deal completed20.47%--
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.